Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00003186 · ClinicalTrials.gov registry record · NA

Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer

A NA study, sponsored by Roswell Park Cancer Institute.

Completed
Registry status
NA
Development phase

NCT00003186: Completed NA study, sponsored by Roswell Park Cancer Institute.

NCT00003186 is a NA study that has completed, run by Roswell Park Cancer Institute. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00003186, a NA study, has completed, sponsored by Roswell Park Cancer Institute.

COMPLETED
Registry status
NA
Development phase

Study Summary

RATIONALE: Diagnostic procedures, such as lymphography, may improve the identification of patients with metastatic colorectal cancer. PURPOSE: Clinical trial to study the effectiveness of lymphography in determining the presence or absence of metastatic colorectal cancer in patients.

Interventions

  • PROCEDURE lymphangiography
  • PROCEDURE sentinel lymph node biopsy
  • DRUG isosulfan blue

Trial Details

FieldValue
Start Date 1997-04
Phase NA
Roswell Park Cancer Institute

365 total trials

What the finished NCT00003186 record still lists

NCT00003186 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 3 interventions - of which lymphangiography is the first listed.

NCT00003186 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00003186 about?

NCT00003186 is a clinical study titled "Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer". RATIONALE: Diagnostic procedures, such as lymphography, may improve the identification of patients with metastatic colorectal cancer. PURPOSE: Clinical trial to study the effectiveness of lymphography in determining the presence or absence of metastatic colorectal cancer in patients.

What is the current status of trial NCT00003186?

This trial is currently completed. It is a NA study. The study started on 1997-04.

What interventions are being tested in trial NCT00003186?

The interventions under investigation include: lymphangiography (PROCEDURE), sentinel lymph node biopsy (PROCEDURE), isosulfan blue (DRUG).

Who is sponsoring clinical trial NCT00003186?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00003186, the US trial registry maintained by the National Library of Medicine. NCT00003186 (unsized enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.